A multi-centre randomized , single-blind, parallel-controlled study of morinidazole plus ceftriaxone or ceftriaxone alone for surgical site infection in class III wounds prevention
Latest Information Update: 24 Sep 2024
At a glance
- Drugs Morinidazole (Primary) ; Ceftriaxone
- Indications Bacterial infections; Infections
- Focus Adverse reactions; Therapeutic Use
- 24 Sep 2024 New trial record
- 01 Sep 2024 Results published in the Journal of Hospital Infection